These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21120535)

  • 21. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
    Dai XM; Zong XH; Akhter MP; Stanley ER
    J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Melatonin and bone status].
    Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
    Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
    Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
    Rifas L; Arackal S; Weitzmann MN
    J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiopathological basis of bone turnover.
    Masi L; Brandi ML
    Q J Nucl Med; 2001 Mar; 45(1):2-6. PubMed ID: 11456372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RANK/RANKL/OPG role in distraction osteogenesis.
    Pérez-Sayáns M; Somoza-Martín JM; Barros-Angueira F; Rey JM; García-García A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):679-86. PubMed ID: 20163972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RANKL signaling in bone physiology and cancer.
    Dougall WC
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):317-22. PubMed ID: 18685382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone remodeling: a role in bone homeostasis].
    Endo I; Matsumoto T
    Nihon Rinsho; 2009 May; 67(5):873-8. PubMed ID: 19432103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
    Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of apoptosis in osteoclasts and osteoblastic cells.
    Xing L; Boyce BF
    Biochem Biophys Res Commun; 2005 Mar; 328(3):709-20. PubMed ID: 15694405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the rank of RANKL in spondylarthritis?
    Loddenkemper K; Burmester GR
    Arthritis Rheum; 2008 Mar; 58(3):641-4. PubMed ID: 18311809
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in basic research of bone metabolism].
    Inoue D; Matsumoto T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():25-33. PubMed ID: 11979916
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteoblast ontogeny and implications for bone pathology: an overview.
    Titorencu I; Pruna V; Jinga VV; Simionescu M
    Cell Tissue Res; 2014 Jan; 355(1):23-33. PubMed ID: 24292720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.
    Krumbholz G; Junker S; Meier FMP; Rickert M; Steinmeyer J; Rehart S; Lange U; Frommer KW; Schett G; Müller-Ladner U; Neumann E
    Clin Exp Rheumatol; 2017; 35(3):406-414. PubMed ID: 28079506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.